Literature DB >> 29571643

Acute Kidney Injury After Total Arch Replacement Combined With Frozen Elephant Trunk Implantation: Incidence, Risk Factors, and Outcome.

Hui Zhou1, Guyan Wang2, Lijing Yang1, Sheng Shi1, Jun Li1, Meng Wang1, Congya Zhang1, Hongyan Li3, Xiangyang Qian4, Xiaogang Sun4, Qian Chang4, Cuntao Yu4.   

Abstract

OBJECTIVES: Acute kidney injury (AKI) is common after thoracic aortic surgery and is a significant predictor of morbidity and mortality. Total arch replacement (TAR) combined with frozen elephant trunk (FET) implantation has been reported to produce satisfactory clinical outcomes, whereas several features of the surgical procedure may induce postoperative AKI. The authors aimed to clarify the incidence of and risk factors for postoperative AKI and the association of AKI with short-term outcomes.
DESIGN: This study was a retrospective analysis of a prospectively collected cohort. A multivariate logistic regression model was used to identify predictors of postoperative AKI.
SETTING: Single center. PARTICIPANTS: Clinical data were analyzed for 553 consecutive patients who underwent TAR combined with FET implantation between 2013 and 2016.
INTERVENTIONS: None
MEASUREMENTS AND MAIN RESULTS: Postoperative AKI was defined using the Kidney Disease Improving Global Outcomes criteria. Postoperative AKI occurred in 77.6% of the whole cohort. Patients in stage 3 AKI were associated with a higher incidence of major adverse events and in-hospital and 90-day mortality (p < 0.001, p < 0.05, p < 0.01, respectively). In the multivariate analysis, male sex (odds ratio [OR] 1.94; 95% confidence interval [95% CI] 1.22-3.18; p = 0.005); older age (per 10 years) (OR 1.37; 95% CI 1.14-1.67; p = 0.001); elevated body mass index (per 5 kg/m2) (OR 1.41; 95% CI 1.08-1.87; p = 0.01); and prolonged cardiopulmonary bypass duration (per 30 minutes) (OR 1.17; 95% CI 1.01-1.37; p = 0.03) were identified as independent predictors of postoperative AKI.
CONCLUSION: TAR combined with FET implantation carries a high-risk for postoperative AKI compared with other types of thoracic aortic surgeries. Cardiopulmonary bypass duration was identified as the only modifiable predictor of AKI, and patients may benefit from moderate hypothermic circulatory arrest instead of deep hypothermic circulatory arrest.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; aortic dissection; risk factors; total arch replacement

Mesh:

Year:  2018        PMID: 29571643     DOI: 10.1053/j.jvca.2018.02.026

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  16 in total

1.  Renal protective effect of the aortic balloon occlusion technique in total arch replacement with frozen elephant trunk.

Authors:  Bowen Zhang; Yanxiang Liu; Hongwei Guo; Yunfeng Li; Yi Shi; Shenghua Liang; Hong Liu; Xiaogang Sun
Journal:  Ann Cardiothorac Surg       Date:  2020-05

2.  Characteristics and outcomes of Stanford type A aortic dissection patients with severe post-operation hyperbilirubinemia: a retrospective cohort study.

Authors:  Xiaolan Chen; Ming Bai; Lijuan Zhao; Yangping Li; Yan Yu; Wei Zhang; Feng Ma; Shiren Sun; Xiangmei Chen
Journal:  J Cardiothorac Surg       Date:  2020-07-28       Impact factor: 1.637

3.  90 days impacts of remote ischemic preconditioning on patients undergoing open total aortic arch replacement: a post-hoc analysis of previous trial.

Authors:  Yimeng Chen; Guyan Wang; Hui Zhou; Lijing Yang; Congya Zhang; Xiying Yang; Guiyu Lei
Journal:  BMC Anesthesiol       Date:  2020-07-09       Impact factor: 2.217

4.  Impact of autologous platelet rich plasma use on postoperative acute kidney injury in type A acute aortic dissection repair: a retrospective cohort analysis.

Authors:  Jiaqi Tong; Liang Cao; Liwei Liu; Mu Jin
Journal:  J Cardiothorac Surg       Date:  2021-01-07       Impact factor: 1.637

5.  Mild hypothermic circulatory arrest with selective cerebral perfusion in open arch surgery.

Authors:  Song-Bo Dong; Kai Zhang; Kai Zhu; Long-Fei Wang; Jun Zheng; Jian-Rong Li; Yong-Min Liu; Li-Zhong Sun; Xu-Dong Pan
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

6.  Moderate and Deep Hypothermic Circulatory Arrest Have Comparable Effects on Severe Systemic Inflammatory Response Syndrome After Total Aortic Arch Replacement in Patients With Type A Aortic Dissection.

Authors:  Yinejie Du; Zhongrong Fang; Yanhua Sun; Congya Zhang; Guiyu Lei; Yimeng Chen; Lijing Yang; Xiying Yang; Jun Li; Guyan Wang
Journal:  Front Surg       Date:  2021-12-06

7.  Total Arch Replacement With Frozen Elephant Trunk Using a NEW "Brain-Heart-First" Strategy for Acute DeBakey Type I Aortic Dissection Can Be Performed Under Mild Hypothermia (≥30°C) With Satisfactory Outcomes.

Authors:  Kangjun Shen; Ling Tan; Hao Tang; Xinmin Zhou; Jun Xiao; Dongshu Xie; Jingyu Li; Yichuan Chen
Journal:  Front Cardiovasc Med       Date:  2022-02-08

8.  Preoperative platelet count, preoperative hemoglobin concentration and deep hypothermic circulatory arrest duration are risk factors for acute kidney injury after pulmonary endarterectomy: a retrospective cohort study.

Authors:  Congya Zhang; Guyan Wang; Hui Zhou; Guiyu Lei; Lijing Yang; Zhongrong Fang; Sheng Shi; Jun Li; Zhiyan Han; Yunhu Song; Sheng Liu
Journal:  J Cardiothorac Surg       Date:  2019-12-30       Impact factor: 1.637

9.  Intraoperative blood transfusion volume is an independent risk factor for postoperative acute kidney injury in type A acute aortic dissection.

Authors:  Yanli Liu; Yuqiang Shang; Ding Long; Li Yu
Journal:  BMC Cardiovasc Disord       Date:  2020-10-14       Impact factor: 2.298

10.  Risk factors analysis of acute kidney injury following open thoracic aortic surgery in the patients with or without acute aortic syndrome: a retrospective study.

Authors:  Xiaochun Ma; Jinzhang Li; Yan Yun; Diming Zhao; Shanghao Chen; Huibo Ma; Zhengjun Wang; Haizhou Zhang; Chengwei Zou; Yuqi Cui
Journal:  J Cardiothorac Surg       Date:  2020-08-07       Impact factor: 1.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.